Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AngioDynamics Inc ANGO

Healthcare Medical Devices
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the... see more

Recent & Breaking News (NDAQ:ANGO)

AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer

Business Wire January 24, 2018

AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results

Business Wire January 4, 2018

Earnings Scheduled For January 4, 2018

Benzinga.com  January 4, 2018

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Business Wire December 19, 2017

AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018

Business Wire December 11, 2017

Mid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike Higher

Benzinga.com  September 28, 2017

Mid-Day Market Update: Exa Corp Rises On Acquisition News; Comtech Shares Plunge

Benzinga.com  September 28, 2017

Mid-Morning Market Update: Markets Edge Lower; BlackBerry Tops Q2 Expectations

Benzinga.com  September 28, 2017

AngioDynamics Reports Fiscal 2018 First Quarter Results

GlobeNewswire September 28, 2017

Earnings Scheduled For September 28, 2017

Benzinga.com  September 28, 2017

Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open

GlobeNewswire September 14, 2017

AngioDynamics to Report Fiscal 2018 First Quarter Financial Results

GlobeNewswire September 14, 2017

AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 13, 2017

AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference

GlobeNewswire August 29, 2017

AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference

GlobeNewswire August 7, 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.

Business Wire July 27, 2017

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO

PR Newswire July 26, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.

Business Wire July 24, 2017

Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc.

PR Newswire July 24, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire July 18, 2017